EASL 2012 Report – CO-PILOT: Emerging, investigative interferon-free HCV treatment
by Bruce Sylvester – Researchers report that combination ABT-450 with ritonavir (ABT-450/r, Abbott) plus ABT-333 plus ribavirin (RBV) is both well tolerated and led to high sustained virological… read more.